About Us
Lighthouse Biosciences, Inc. is the result of several years of academic research predicated upon the development of in vitro molecular diagnostics for the rapid and accurate detection and screening of pathogenic organisms. The Company was founded in 2005 by three University of Rochester researchers: Christopher M. Strohsahl, Benjamin L. Miller, and Todd D. Krauss. The founders of Lighthouse are committed to developing state-of-the-art diagnostic solutions that can deliver highly accurate results in minutes-to-hours as opposed to days. Initially focussing on healthcare applications, Lighthouse will transform medical diagnostics by enabling physicians to diagnose and treat infectious diseases as rapidly and accurately as possible, thereby improving the quality of patient care and lowering provider costs.